APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Zoste Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Herpes Zoste Drug Market Analysis and Forecast 2026-2032

26 December 2025212 pages

Choose your research edition.

Industry ResearchHerpes Zoste Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Zoste Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Herpes Zoste Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Zoste Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Zoste Drug Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Herpes Zoste Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Herpes Zoste Drug's global sales reached XX (W Units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Merck & Co., Inc. as the global sales leader, a title it has maintained for several consecutive years. Notably, Merck & Co., Inc.'s performance in primary markets is also remarkable. In the Chinese market, sales were XX (W Units), a change of XX% from the previous year. In Europe, sales were XX (W Units), showing a year-on-year of XX%. In the US, sales were XX (W Units), a year-on-year change of XX%.

The major global manufacturers in the Herpes Zoste Drug market include Merck & Co., Inc., Beijing Minhai Biotechnology Co., Ltd, Astellas Pharma Inc., TSRL, Inc., ReceptoPharm, Inc., NAL Pharmaceuticals Ltd., GlaxoSmithKline Plc, GeneOne Life Science, Inc. and Foamix Pharmaceuticals Ltd., etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Herpes Zoste Drug production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Herpes Zoste Drug by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Herpes Zoste Drug, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Herpes Zoste Drug, also provides the consumption of main regions and countries. Of the upcoming market potential for Herpes Zoste Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herpes Zoste Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Herpes Zoste Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Herpes Zoste Drug sales, projected growth trends, production technology, application and end-user industry.

Herpes Zoste Drug Segment by Company

Merck & Co., Inc.

Beijing Minhai Biotechnology Co., Ltd

Astellas Pharma Inc.

TSRL, Inc.

ReceptoPharm, Inc.

NAL Pharmaceuticals Ltd.

GlaxoSmithKline Plc

GeneOne Life Science, Inc.

Foamix Pharmaceuticals Ltd.

Epiphany Biosciences, Inc.

ContraVir Pharmaceuticals, Inc.

Herpes Zoste Drug Segment by Type

FV-100

GLS-5100

GSK-1437173A

NAL-3221

Amenamevir

Acyclovir

Others

Herpes Zoste Drug Segment by Application

Clinic

Hospital

Others

Herpes Zoste Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Zoste Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Zoste Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Zoste Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Herpes Zoste Drug production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Herpes Zoste Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Herpes Zoste Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Zoste Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Herpes Zoste Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. FV-100 Major Manufacturers Table 3. GLS-5100 Major Manufacturers Table 4. GSK-1437173A Major Manufacturers Table 5. NAL-3221 Major Manufacturers Table 6. Amenamevir Major Manufacturers Table 7. Acyclovir Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Herpes Zoste Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Clinic Major Manufacturers Table 11. Hospital Major Manufacturers Table 12. Others Major Manufacturers Table 13. Herpes Zoste Drug Industry Trends Table 14. Herpes Zoste Drug Industry Drivers Table 15. Herpes Zoste Drug Industry Opportunities and Challenges Table 16. Herpes Zoste Drug Industry Restraints Table 17. Global Herpes Zoste Drug Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Herpes Zoste Drug Production by Region (2021-2026) & (W Units) Table 19. Global Herpes Zoste Drug Production by Region (2027-2032) & (W Units) Table 20. Global Herpes Zoste Drug Production Market Share by Region (2021-2026) Table 21. Global Herpes Zoste Drug Production Market Share by Region (2027-2032) Table 22. Global Herpes Zoste Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Herpes Zoste Drug Revenue by Region (2021-2026) & (US$ Million) Table 24. Global Herpes Zoste Drug Revenue by Region (2027-2032) & (US$ Million) Table 25. Global Herpes Zoste Drug Revenue Market Share by Region (2021-2026) Table 26. Global Herpes Zoste Drug Revenue Market Share by Region (2027-2032) Table 27. Global Herpes Zoste Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 28. Global Herpes Zoste Drug Sales by Region (2021-2026) & (W Units) Table 29. Global Herpes Zoste Drug Sales by Region (2027-2032) & (W Units) Table 30. Global Herpes Zoste Drug Sales Market Share by Region (2021-2026) Table 31. Global Herpes Zoste Drug Sales Market Share by Region (2027-2032) Table 32. Global Herpes Zoste Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Herpes Zoste Drug Revenue Market Share by Manufacturers (2021-2026) Table 34. Global Herpes Zoste Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 35. Global Herpes Zoste Drug Sales Market Share by Manufacturers (2021-2026) Table 36. Global Herpes Zoste Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 37. Global Herpes Zoste Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 38. Global Herpes Zoste Drug Key Manufacturers Manufacturing Sites & Headquarters Table 39. Global Herpes Zoste Drug Manufacturers, Product Type & Application Table 40. Global Herpes Zoste Drug Manufacturers Commercialization Time Table 41. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 42. Global Herpes Zoste Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 43. Global Herpes Zoste Drug Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Herpes Zoste Drug Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Herpes Zoste Drug Revenue Market Share by Type (2021-2026) Table 46. Global Herpes Zoste Drug Revenue Market Share by Type (2027-2032) Table 47. Global Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 48. Global Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 49. Global Herpes Zoste Drug Sales Market Share by Type (2021-2026) Table 50. Global Herpes Zoste Drug Sales Market Share by Type (2027-2032) Table 51. Global Herpes Zoste Drug Price by Type (2021-2026) & (US$/Unit) Table 52. Global Herpes Zoste Drug Price by Type (2027-2032) & (US$/Unit) Table 53. Global Herpes Zoste Drug Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Herpes Zoste Drug Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Herpes Zoste Drug Revenue Market Share by Application (2021-2026) Table 56. Global Herpes Zoste Drug Revenue Market Share by Application (2027-2032) Table 57. Global Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 58. Global Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 59. Global Herpes Zoste Drug Sales Market Share by Application (2021-2026) Table 60. Global Herpes Zoste Drug Sales Market Share by Application (2027-2032) Table 61. Global Herpes Zoste Drug Price by Application (2021-2026) & (US$/Unit) Table 62. Global Herpes Zoste Drug Price by Application (2027-2032) & (US$/Unit) Table 63. Merck & Co., Inc. Company Information Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck & Co., Inc. Herpes Zoste Drug Product Portfolio Table 67. Merck & Co., Inc. Recent Development Table 68. Beijing Minhai Biotechnology Co., Ltd Company Information Table 69. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 70. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio Table 72. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 73. Astellas Pharma Inc. Company Information Table 74. Astellas Pharma Inc. Business Overview Table 75. Astellas Pharma Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio Table 77. Astellas Pharma Inc. Recent Development Table 78. TSRL, Inc. Company Information Table 79. TSRL, Inc. Business Overview Table 80. TSRL, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. TSRL, Inc. Herpes Zoste Drug Product Portfolio Table 82. TSRL, Inc. Recent Development Table 83. ReceptoPharm, Inc. Company Information Table 84. ReceptoPharm, Inc. Business Overview Table 85. ReceptoPharm, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio Table 87. ReceptoPharm, Inc. Recent Development Table 88. NAL Pharmaceuticals Ltd. Company Information Table 89. NAL Pharmaceuticals Ltd. Business Overview Table 90. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio Table 92. NAL Pharmaceuticals Ltd. Recent Development Table 93. GlaxoSmithKline Plc Company Information Table 94. GlaxoSmithKline Plc Business Overview Table 95. GlaxoSmithKline Plc Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio Table 97. GlaxoSmithKline Plc Recent Development Table 98. GeneOne Life Science, Inc. Company Information Table 99. GeneOne Life Science, Inc. Business Overview Table 100. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio Table 102. GeneOne Life Science, Inc. Recent Development Table 103. Foamix Pharmaceuticals Ltd. Company Information Table 104. Foamix Pharmaceuticals Ltd. Business Overview Table 105. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio Table 107. Foamix Pharmaceuticals Ltd. Recent Development Table 108. Epiphany Biosciences, Inc. Company Information Table 109. Epiphany Biosciences, Inc. Business Overview Table 110. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio Table 112. Epiphany Biosciences, Inc. Recent Development Table 113. ContraVir Pharmaceuticals, Inc. Company Information Table 114. ContraVir Pharmaceuticals, Inc. Business Overview Table 115. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio Table 117. ContraVir Pharmaceuticals, Inc. Recent Development Table 118. North America Herpes Zoste Drug Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Herpes Zoste Drug Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 121. North America Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 122. North America Herpes Zoste Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 123. North America Herpes Zoste Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 124. North America Herpes Zoste Drug Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Herpes Zoste Drug Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 127. North America Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 128. North America Herpes Zoste Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 129. North America Herpes Zoste Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 130. North America Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Herpes Zoste Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Herpes Zoste Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 134. North America Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 135. North America Herpes Zoste Drug Sales by Country (2027-2032) & (W Units) Table 136. North America Herpes Zoste Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 137. North America Herpes Zoste Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 138. United States Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 139. Canada Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 140. Mexico Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 141. Europe Herpes Zoste Drug Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Herpes Zoste Drug Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 144. Europe Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 145. Europe Herpes Zoste Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Europe Herpes Zoste Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Europe Herpes Zoste Drug Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Herpes Zoste Drug Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 150. Europe Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 151. Europe Herpes Zoste Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Europe Herpes Zoste Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Europe Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Herpes Zoste Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Herpes Zoste Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 157. Europe Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 158. Europe Herpes Zoste Drug Sales by Country (2027-2032) & (W Units) Table 159. Europe Herpes Zoste Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Europe Herpes Zoste Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Germany Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 162. France Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 163. U.K. Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 164. Italy Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 165. Russia Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 166. Spain Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 169. Sweden Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 170. Poland Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 171. China Herpes Zoste Drug Revenue by Type (2021-2026) & (US$ Million) Table 172. China Herpes Zoste Drug Revenue by Type (2027-2032) & (US$ Million) Table 173. China Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 174. China Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 175. China Herpes Zoste Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 176. China Herpes Zoste Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 177. China Herpes Zoste Drug Revenue by Application (2021-2026) & (US$ Million) Table 178. China Herpes Zoste Drug Revenue by Application (2027-2032) & (US$ Million) Table 179. China Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 180. China Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 181. China Herpes Zoste Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 182. China Herpes Zoste Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Herpes Zoste Drug Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Herpes Zoste Drug Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 186. Asia Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 187. Asia Herpes Zoste Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Asia Herpes Zoste Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Asia Herpes Zoste Drug Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Herpes Zoste Drug Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 192. Asia Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 193. Asia Herpes Zoste Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Asia Herpes Zoste Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Herpes Zoste Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Herpes Zoste Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 199. Asia Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 200. Asia Herpes Zoste Drug Sales by Country (2027-2032) & (W Units) Table 201. Asia Herpes Zoste Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Asia Herpes Zoste Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Japan Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 204. South Korea Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 205. India Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 206. Australia Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Herpes Zoste Drug Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Herpes Zoste Drug Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 212. SAMEA Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 213. SAMEA Herpes Zoste Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 214. SAMEA Herpes Zoste Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 215. SAMEA Herpes Zoste Drug Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Herpes Zoste Drug Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 218. SAMEA Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 219. SAMEA Herpes Zoste Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 220. SAMEA Herpes Zoste Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 221. SAMEA Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Herpes Zoste Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Herpes Zoste Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 225. SAMEA Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 226. SAMEA Herpes Zoste Drug Sales by Country (2027-2032) & (W Units) Table 227. SAMEA Herpes Zoste Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 228. SAMEA Herpes Zoste Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Brazil Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 230. Argentina Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 231. Chile Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 232. Colombia Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 233. Peru Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 235. Israel Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 236. UAE Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 237. Turkey Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 238. Iran Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 239. Egypt Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Herpes Zoste Drug Distributors List Table 243. Herpes Zoste Drug Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Herpes Zoste Drug Product Image Figure 2. Global Herpes Zoste Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Zoste Drug Market Size Share 2021 VS 2025 VS 2032 Figure . FV-100 Image Figure 1. GLS-5100 Image Figure 2. GSK-1437173A Image Figure 3. NAL-3221 Image Figure 4. Amenamevir Image Figure 5. Acyclovir Image Figure 6. Others Image Figure 7. Global Herpes Zoste Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Herpes Zoste Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Others Image Figure 12. Global Herpes Zoste Drug Capacity, Capacity Utilization (2021-2032) & (W Units) Figure 13. Global Herpes Zoste Drug Production by Region: 2021 VS 2025 VS 2032 (W Units) Figure 14. Global Herpes Zoste Drug Production Market Share by Region: 2025 Versus 2032 Figure 15. Global Herpes Zoste Drug Production Market Share by Region (2021-2032) Figure 16. North America Herpes Zoste Drug Production Growth Rate (2021-2032) & (W Units) Figure 17. Europe Herpes Zoste Drug Production Growth Rate (2021-2032) & (W Units) Figure 18. China Herpes Zoste Drug Production Growth Rate (2021-2032) & (W Units) Figure 19. Japan Herpes Zoste Drug Production Growth Rate (2021-2032) & (W Units) Figure 20. Global Herpes Zoste Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Herpes Zoste Drug Revenue (2021-2032) & (US$ Million) Figure 22. Global Herpes Zoste Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Herpes Zoste Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 24. Global Herpes Zoste Drug Revenue Market Share by Region (2021-2032) Figure 25. Global Herpes Zoste Drug Sales (2021-2032) & (W Units) Figure 26. Global Herpes Zoste Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Herpes Zoste Drug Sales Market Share by Region (2021-2032) Figure 28. North America Herpes Zoste Drug Sales YoY (2021-2032) & (W Units) Figure 29. Europe Herpes Zoste Drug Sales YoY (2021-2032) & (W Units) Figure 30. China Herpes Zoste Drug Sales YoY (2021-2032) & (W Units) Figure 31. Asia (Excluding China) Herpes Zoste Drug Sales YoY (2021-2032) & (W Units) Figure 32. South America, Middle East and Africa Herpes Zoste Drug Sales YoY (2021-2032) & (W Units) Figure 33. Global Herpes Zoste Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 34. Global Herpes Zoste Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 35. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Global Herpes Zoste Drug Revenue Market Share by Type (2021-2032) Figure 37. Global Herpes Zoste Drug Sales Market Share by Type (2021-2032) Figure 38. Global Herpes Zoste Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Herpes Zoste Drug Sales Market Share by Application (2021-2032) Figure 40. North America Herpes Zoste Drug Revenue Share by Type (2021-2032) Figure 41. North America Herpes Zoste Drug Sales Share by Type (2021-2032) Figure 42. North America Herpes Zoste Drug Revenue Share by Application (2021-2032) Figure 43. North America Herpes Zoste Drug Sales Share by Application (2021-2032) Figure 44. North America Herpes Zoste Drug Revenue Share by Country (2021-2032) Figure 45. North America Herpes Zoste Drug Sales Share by Country (2021-2032) Figure 46. Europe Herpes Zoste Drug Revenue Share by Type (2021-2032) Figure 47. Europe Herpes Zoste Drug Sales Share by Type (2021-2032) Figure 48. Europe Herpes Zoste Drug Revenue Share by Application (2021-2032) Figure 49. Europe Herpes Zoste Drug Sales Share by Application (2021-2032) Figure 50. Europe Herpes Zoste Drug Revenue Share by Country (2021-2032) Figure 51. Europe Herpes Zoste Drug Sales Share by Country (2021-2032) Figure 52. China Herpes Zoste Drug Revenue Share by Type (2021-2032) Figure 53. China Herpes Zoste Drug Sales Share by Type (2021-2032) Figure 54. China Herpes Zoste Drug Revenue Share by Application (2021-2032) Figure 55. China Herpes Zoste Drug Sales Share by Application (2021-2032) Figure 56. Asia Herpes Zoste Drug Revenue Share by Type (2021-2032) Figure 57. Asia Herpes Zoste Drug Sales Share by Type (2021-2032) Figure 58. Asia Herpes Zoste Drug Revenue Share by Application (2021-2032) Figure 59. Asia Herpes Zoste Drug Sales Share by Application (2021-2032) Figure 60. Asia Herpes Zoste Drug Revenue Share by Country (2021-2032) Figure 61. Asia Herpes Zoste Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Herpes Zoste Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Herpes Zoste Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Herpes Zoste Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Herpes Zoste Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Herpes Zoste Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Herpes Zoste Drug Sales Share by Country (2021-2032) Figure 68. Herpes Zoste Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Herpes Zoste Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • FV-100
  • GLS-5100
  • GSK-1437173A
  • NAL-3221
  • Amenamevir
  • Acyclovir
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Merck & Co., Inc.
  • Beijing Minhai Biotechnology Co., Ltd
  • Astellas Pharma Inc.
  • TSRL, Inc.
  • ReceptoPharm, Inc.
  • NAL Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • GeneOne Life Science, Inc.
  • Foamix Pharmaceuticals Ltd.
  • Epiphany Biosciences, Inc.
  • ContraVir Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Herpes Zoste Drug Market by Type
  3. 1.2.1 Global Herpes Zoste Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 FV-100
  5. 1.2.3 GLS-5100
  6. 1.2.4 GSK-1437173A
  7. 1.2.5 NAL-3221
  8. 1.2.6 Amenamevir
  9. 1.2.7 Acyclovir
  10. 1.2.8 Others
  11. 1.3 Herpes Zoste Drug Market by Application
  12. 1.3.1 Global Herpes Zoste Drug Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Clinic
  14. 1.3.3 Hospital
  15. 1.3.4 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Herpes Zoste Drug Market Dynamics
  1. 2.1 Herpes Zoste Drug Industry Trends
  2. 2.2 Herpes Zoste Drug Industry Drivers
  3. 2.3 Herpes Zoste Drug Industry Opportunities and Challenges
  4. 2.4 Herpes Zoste Drug Industry Restraints
3 Global Herpes Zoste Drug Production Overview
  1. 3.1 Global Herpes Zoste Drug Production Capacity (2021-2032)
  2. 3.2 Global Herpes Zoste Drug Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Herpes Zoste Drug Production by Region
  4. 3.3.1 Global Herpes Zoste Drug Production by Region (2021-2026)
  5. 3.3.2 Global Herpes Zoste Drug Production by Region (2027-2032)
  6. 3.3.3 Global Herpes Zoste Drug Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Herpes Zoste Drug Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Herpes Zoste Drug Revenue by Region
  3. 4.2.1 Global Herpes Zoste Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Herpes Zoste Drug Revenue by Region (2021-2026)
  5. 4.2.3 Global Herpes Zoste Drug Revenue by Region (2027-2032)
  6. 4.2.4 Global Herpes Zoste Drug Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Herpes Zoste Drug Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Herpes Zoste Drug Sales by Region
  9. 4.4.1 Global Herpes Zoste Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Herpes Zoste Drug Sales by Region (2021-2026)
  11. 4.4.3 Global Herpes Zoste Drug Sales by Region (2027-2032)
  12. 4.4.4 Global Herpes Zoste Drug Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Herpes Zoste Drug Revenue by Manufacturers
  2. 5.1.1 Global Herpes Zoste Drug Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Herpes Zoste Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Herpes Zoste Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Herpes Zoste Drug Sales by Manufacturers
  6. 5.2.1 Global Herpes Zoste Drug Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Herpes Zoste Drug Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Herpes Zoste Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Herpes Zoste Drug Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Herpes Zoste Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Herpes Zoste Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Herpes Zoste Drug Manufacturers, Product Type & Application
  13. 5.7 Global Herpes Zoste Drug Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Herpes Zoste Drug Market CR5 and HHI
  16. 5.8.2 2025 Herpes Zoste Drug Tier 1, Tier 2, and Tier 3
6 Herpes Zoste Drug Market by Type
  1. 6.1 Global Herpes Zoste Drug Revenue by Type
  2. 6.1.1 Global Herpes Zoste Drug Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Herpes Zoste Drug Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Herpes Zoste Drug Sales by Type
  5. 6.2.1 Global Herpes Zoste Drug Sales by Type (2021-2032) & (W Units)
  6. 6.2.2 Global Herpes Zoste Drug Sales Market Share by Type (2021-2032)
  7. 6.3 Global Herpes Zoste Drug Price by Type
7 Herpes Zoste Drug Market by Application
  1. 7.1 Global Herpes Zoste Drug Revenue by Application
  2. 7.1.1 Global Herpes Zoste Drug Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Herpes Zoste Drug Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Herpes Zoste Drug Sales by Application
  5. 7.2.1 Global Herpes Zoste Drug Sales by Application (2021-2032) & (W Units)
  6. 7.2.2 Global Herpes Zoste Drug Sales Market Share by Application (2021-2032)
  7. 7.3 Global Herpes Zoste Drug Price by Application
8 Company Profiles
  1. 8.1 Merck & Co., Inc.
  2. 8.1.1 Merck & Co., Inc. Company Information
  3. 8.1.2 Merck & Co., Inc. Business Overview
  4. 8.1.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co., Inc. Herpes Zoste Drug Product Portfolio
  6. 8.1.5 Merck & Co., Inc. Recent Developments
  7. 8.2 Beijing Minhai Biotechnology Co., Ltd
  8. 8.2.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  9. 8.2.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  10. 8.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio
  12. 8.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  13. 8.3 Astellas Pharma Inc.
  14. 8.3.1 Astellas Pharma Inc. Company Information
  15. 8.3.2 Astellas Pharma Inc. Business Overview
  16. 8.3.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio
  18. 8.3.5 Astellas Pharma Inc. Recent Developments
  19. 8.4 TSRL, Inc.
  20. 8.4.1 TSRL, Inc. Company Information
  21. 8.4.2 TSRL, Inc. Business Overview
  22. 8.4.3 TSRL, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 TSRL, Inc. Herpes Zoste Drug Product Portfolio
  24. 8.4.5 TSRL, Inc. Recent Developments
  25. 8.5 ReceptoPharm, Inc.
  26. 8.5.1 ReceptoPharm, Inc. Company Information
  27. 8.5.2 ReceptoPharm, Inc. Business Overview
  28. 8.5.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio
  30. 8.5.5 ReceptoPharm, Inc. Recent Developments
  31. 8.6 NAL Pharmaceuticals Ltd.
  32. 8.6.1 NAL Pharmaceuticals Ltd. Company Information
  33. 8.6.2 NAL Pharmaceuticals Ltd. Business Overview
  34. 8.6.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
  36. 8.6.5 NAL Pharmaceuticals Ltd. Recent Developments
  37. 8.7 GlaxoSmithKline Plc
  38. 8.7.1 GlaxoSmithKline Plc Company Information
  39. 8.7.2 GlaxoSmithKline Plc Business Overview
  40. 8.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio
  42. 8.7.5 GlaxoSmithKline Plc Recent Developments
  43. 8.8 GeneOne Life Science, Inc.
  44. 8.8.1 GeneOne Life Science, Inc. Company Information
  45. 8.8.2 GeneOne Life Science, Inc. Business Overview
  46. 8.8.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio
  48. 8.8.5 GeneOne Life Science, Inc. Recent Developments
  49. 8.9 Foamix Pharmaceuticals Ltd.
  50. 8.9.1 Foamix Pharmaceuticals Ltd. Company Information
  51. 8.9.2 Foamix Pharmaceuticals Ltd. Business Overview
  52. 8.9.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
  54. 8.9.5 Foamix Pharmaceuticals Ltd. Recent Developments
  55. 8.10 Epiphany Biosciences, Inc.
  56. 8.10.1 Epiphany Biosciences, Inc. Company Information
  57. 8.10.2 Epiphany Biosciences, Inc. Business Overview
  58. 8.10.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio
  60. 8.10.5 Epiphany Biosciences, Inc. Recent Developments
  61. 8.11 ContraVir Pharmaceuticals, Inc.
  62. 8.11.1 ContraVir Pharmaceuticals, Inc. Company Information
  63. 8.11.2 ContraVir Pharmaceuticals, Inc. Business Overview
  64. 8.11.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio
  66. 8.11.5 ContraVir Pharmaceuticals, Inc. Recent Developments
9 North America
  1. 9.1 North America Herpes Zoste Drug Market Size by Type
  2. 9.1.1 North America Herpes Zoste Drug Revenue by Type (2021-2032)
  3. 9.1.2 North America Herpes Zoste Drug Sales by Type (2021-2032)
  4. 9.1.3 North America Herpes Zoste Drug Price by Type (2021-2032)
  5. 9.2 North America Herpes Zoste Drug Market Size by Application
  6. 9.2.1 North America Herpes Zoste Drug Revenue by Application (2021-2032)
  7. 9.2.2 North America Herpes Zoste Drug Sales by Application (2021-2032)
  8. 9.2.3 North America Herpes Zoste Drug Price by Application (2021-2032)
  9. 9.3 North America Herpes Zoste Drug Market Size by Country
  10. 9.3.1 North America Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Herpes Zoste Drug Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Herpes Zoste Drug Market Size by Type
  2. 10.1.1 Europe Herpes Zoste Drug Revenue by Type (2021-2032)
  3. 10.1.2 Europe Herpes Zoste Drug Sales by Type (2021-2032)
  4. 10.1.3 Europe Herpes Zoste Drug Price by Type (2021-2032)
  5. 10.2 Europe Herpes Zoste Drug Market Size by Application
  6. 10.2.1 Europe Herpes Zoste Drug Revenue by Application (2021-2032)
  7. 10.2.2 Europe Herpes Zoste Drug Sales by Application (2021-2032)
  8. 10.2.3 Europe Herpes Zoste Drug Price by Application (2021-2032)
  9. 10.3 Europe Herpes Zoste Drug Market Size by Country
  10. 10.3.1 Europe Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Herpes Zoste Drug Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Herpes Zoste Drug Market Size by Type
  2. 11.1.1 China Herpes Zoste Drug Revenue by Type (2021-2032)
  3. 11.1.2 China Herpes Zoste Drug Sales by Type (2021-2032)
  4. 11.1.3 China Herpes Zoste Drug Price by Type (2021-2032)
  5. 11.2 China Herpes Zoste Drug Market Size by Application
  6. 11.2.1 China Herpes Zoste Drug Revenue by Application (2021-2032)
  7. 11.2.2 China Herpes Zoste Drug Sales by Application (2021-2032)
  8. 11.2.3 China Herpes Zoste Drug Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Herpes Zoste Drug Market Size by Type
  2. 12.1.1 Asia Herpes Zoste Drug Revenue by Type (2021-2032)
  3. 12.1.2 Asia Herpes Zoste Drug Sales by Type (2021-2032)
  4. 12.1.3 Asia Herpes Zoste Drug Price by Type (2021-2032)
  5. 12.2 Asia Herpes Zoste Drug Market Size by Application
  6. 12.2.1 Asia Herpes Zoste Drug Revenue by Application (2021-2032)
  7. 12.2.2 Asia Herpes Zoste Drug Sales by Application (2021-2032)
  8. 12.2.3 Asia Herpes Zoste Drug Price by Application (2021-2032)
  9. 12.3 Asia Herpes Zoste Drug Market Size by Country
  10. 12.3.1 Asia Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Herpes Zoste Drug Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Herpes Zoste Drug Market Size by Type
  2. 13.1.1 SAMEA Herpes Zoste Drug Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Herpes Zoste Drug Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Herpes Zoste Drug Price by Type (2021-2032)
  5. 13.2 SAMEA Herpes Zoste Drug Market Size by Application
  6. 13.2.1 SAMEA Herpes Zoste Drug Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Herpes Zoste Drug Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Herpes Zoste Drug Price by Application (2021-2032)
  9. 13.3 SAMEA Herpes Zoste Drug Market Size by Country
  10. 13.3.1 SAMEA Herpes Zoste Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Herpes Zoste Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Herpes Zoste Drug Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Herpes Zoste Drug Value Chain Analysis
  2. 14.1.1 Herpes Zoste Drug Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Herpes Zoste Drug Production Mode & Process
  6. 14.2 Herpes Zoste Drug Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Herpes Zoste Drug Distributors
  9. 14.2.3 Herpes Zoste Drug Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst